nodes	percent_of_prediction	percent_of_DWPC	metapath
Triamterene—CYP1A2—Carmustine—melanoma	0.361	0.417	CbGbCtD
Triamterene—CYP1A2—Vemurafenib—melanoma	0.285	0.33	CbGbCtD
Triamterene—CYP1A2—Dacarbazine—melanoma	0.219	0.253	CbGbCtD
Triamterene—SCNN1A—hair follicle—melanoma	0.0183	0.253	CbGeAlD
Triamterene—Lamotrigine—SCN10A—melanoma	0.0168	0.82	CrCbGaD
Triamterene—SCNN1G—mammalian vulva—melanoma	0.00928	0.128	CbGeAlD
Triamterene—SCNN1B—mammalian vulva—melanoma	0.00784	0.108	CbGeAlD
Triamterene—SCNN1A—mammalian vulva—melanoma	0.00724	0.1	CbGeAlD
Triamterene—SCNN1D—head—melanoma	0.00664	0.0918	CbGeAlD
Triamterene—SCNN1B—head—melanoma	0.00561	0.0776	CbGeAlD
Triamterene—SCNN1A—head—melanoma	0.00518	0.0717	CbGeAlD
Triamterene—SCNN1D—lymph node—melanoma	0.00465	0.0643	CbGeAlD
Triamterene—SCNN1B—lymph node—melanoma	0.00393	0.0543	CbGeAlD
Triamterene—Lamotrigine—ABCB1—melanoma	0.00369	0.18	CrCbGaD
Triamterene—SCNN1A—lymph node—melanoma	0.00363	0.0502	CbGeAlD
Triamterene—Azotaemia—Carmustine—melanoma	0.00232	0.076	CcSEcCtD
Triamterene—Photosensitivity—Vemurafenib—melanoma	0.00193	0.0633	CcSEcCtD
Triamterene—Photosensitivity reaction—Vemurafenib—melanoma	0.00134	0.0439	CcSEcCtD
Triamterene—Anaphylactic shock—Vemurafenib—melanoma	0.000835	0.0273	CcSEcCtD
Triamterene—Hypokalaemia—Carmustine—melanoma	0.000818	0.0268	CcSEcCtD
Triamterene—Hypokalaemia—Temozolomide—melanoma	0.00079	0.0259	CcSEcCtD
Triamterene—Fatigue—Vemurafenib—melanoma	0.00072	0.0236	CcSEcCtD
Triamterene—Photosensitivity reaction—Temozolomide—melanoma	0.000685	0.0224	CcSEcCtD
Triamterene—Hypersensitivity—Vemurafenib—melanoma	0.000615	0.0201	CcSEcCtD
Triamterene—Asthenia—Vemurafenib—melanoma	0.000599	0.0196	CcSEcCtD
Triamterene—Diarrhoea—Vemurafenib—melanoma	0.000571	0.0187	CcSEcCtD
Triamterene—Dizziness—Vemurafenib—melanoma	0.000552	0.0181	CcSEcCtD
Triamterene—Vomiting—Vemurafenib—melanoma	0.000531	0.0174	CcSEcCtD
Triamterene—Rash—Vemurafenib—melanoma	0.000526	0.0172	CcSEcCtD
Triamterene—Dermatitis—Vemurafenib—melanoma	0.000526	0.0172	CcSEcCtD
Triamterene—Headache—Vemurafenib—melanoma	0.000523	0.0171	CcSEcCtD
Triamterene—SCNN1G—Transmembrane transport of small molecules—ABCB5—melanoma	0.000516	0.0466	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—ABCB5—melanoma	0.000516	0.0466	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—ABCB5—melanoma	0.000516	0.0466	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—ABCB5—melanoma	0.000516	0.0466	CbGpPWpGaD
Triamterene—Anaphylactic shock—Bleomycin—melanoma	0.000506	0.0166	CcSEcCtD
Triamterene—Nausea—Vemurafenib—melanoma	0.000496	0.0162	CcSEcCtD
Triamterene—Thrombocytopenia—Bleomycin—melanoma	0.000495	0.0162	CcSEcCtD
Triamterene—Thrombocytopenia—Dactinomycin—melanoma	0.000462	0.0151	CcSEcCtD
Triamterene—Dry mouth—Temozolomide—melanoma	0.000435	0.0142	CcSEcCtD
Triamterene—Jaundice—Docetaxel—melanoma	0.000434	0.0142	CcSEcCtD
Triamterene—Thrombocytopenia—Carmustine—melanoma	0.000432	0.0141	CcSEcCtD
Triamterene—Anaphylactic shock—Temozolomide—melanoma	0.000427	0.014	CcSEcCtD
Triamterene—Thrombocytopenia—Temozolomide—melanoma	0.000418	0.0137	CcSEcCtD
Triamterene—Fatigue—Dactinomycin—melanoma	0.000407	0.0133	CcSEcCtD
Triamterene—Hypersensitivity—Bleomycin—melanoma	0.000373	0.0122	CcSEcCtD
Triamterene—Fatigue—Temozolomide—melanoma	0.000368	0.012	CcSEcCtD
Triamterene—Asthenia—Bleomycin—melanoma	0.000363	0.0119	CcSEcCtD
Triamterene—SCNN1B—Transmembrane transport of small molecules—ARL2—melanoma	0.000358	0.0323	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—ARL2—melanoma	0.000358	0.0323	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—ARL2—melanoma	0.000358	0.0323	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—ARL2—melanoma	0.000358	0.0323	CbGpPWpGaD
Triamterene—Hypersensitivity—Dactinomycin—melanoma	0.000348	0.0114	CcSEcCtD
Triamterene—Asthenia—Dactinomycin—melanoma	0.000338	0.0111	CcSEcCtD
Triamterene—Hypersensitivity—Carmustine—melanoma	0.000325	0.0106	CcSEcCtD
Triamterene—Diarrhoea—Dactinomycin—melanoma	0.000323	0.0106	CcSEcCtD
Triamterene—Vomiting—Bleomycin—melanoma	0.000322	0.0105	CcSEcCtD
Triamterene—Rash—Bleomycin—melanoma	0.000319	0.0104	CcSEcCtD
Triamterene—Dermatitis—Bleomycin—melanoma	0.000319	0.0104	CcSEcCtD
Triamterene—Asthenia—Carmustine—melanoma	0.000317	0.0104	CcSEcCtD
Triamterene—Hypersensitivity—Temozolomide—melanoma	0.000314	0.0103	CcSEcCtD
Triamterene—Asthenia—Temozolomide—melanoma	0.000306	0.01	CcSEcCtD
Triamterene—Diarrhoea—Carmustine—melanoma	0.000302	0.00989	CcSEcCtD
Triamterene—Nausea—Bleomycin—melanoma	0.0003	0.00983	CcSEcCtD
Triamterene—Vomiting—Dactinomycin—melanoma	0.0003	0.00982	CcSEcCtD
Triamterene—Rash—Dactinomycin—melanoma	0.000297	0.00973	CcSEcCtD
Triamterene—Dizziness—Carmustine—melanoma	0.000292	0.00955	CcSEcCtD
Triamterene—Diarrhoea—Temozolomide—melanoma	0.000292	0.00955	CcSEcCtD
Triamterene—CYP1A2—Sulindac Metabolic Pathway—CYP1B1—melanoma	0.00029	0.0262	CbGpPWpGaD
Triamterene—Dry mouth—Docetaxel—melanoma	0.000289	0.00947	CcSEcCtD
Triamterene—Anaphylactic shock—Docetaxel—melanoma	0.000284	0.00929	CcSEcCtD
Triamterene—Dizziness—Temozolomide—melanoma	0.000282	0.00923	CcSEcCtD
Triamterene—Vomiting—Carmustine—melanoma	0.000281	0.00919	CcSEcCtD
Triamterene—Nausea—Dactinomycin—melanoma	0.00028	0.00917	CcSEcCtD
Triamterene—Rash—Carmustine—melanoma	0.000278	0.00911	CcSEcCtD
Triamterene—Dermatitis—Carmustine—melanoma	0.000278	0.0091	CcSEcCtD
Triamterene—Thrombocytopenia—Docetaxel—melanoma	0.000278	0.00909	CcSEcCtD
Triamterene—Headache—Carmustine—melanoma	0.000277	0.00905	CcSEcCtD
Triamterene—Vomiting—Temozolomide—melanoma	0.000271	0.00888	CcSEcCtD
Triamterene—SCNN1A—Transmembrane transport of small molecules—SLC15A2—melanoma	0.000271	0.0245	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—SLC15A2—melanoma	0.000271	0.0245	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—SLC15A2—melanoma	0.000271	0.0245	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—SLC15A2—melanoma	0.000271	0.0245	CbGpPWpGaD
Triamterene—Rash—Temozolomide—melanoma	0.000269	0.0088	CcSEcCtD
Triamterene—Dermatitis—Temozolomide—melanoma	0.000269	0.0088	CcSEcCtD
Triamterene—Headache—Temozolomide—melanoma	0.000267	0.00875	CcSEcCtD
Triamterene—Nausea—Carmustine—melanoma	0.000262	0.00858	CcSEcCtD
Triamterene—SCNN1G—Transmembrane transport of small molecules—SLC17A5—melanoma	0.000261	0.0236	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—SLC17A5—melanoma	0.000261	0.0236	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—SLC17A5—melanoma	0.000261	0.0236	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—SLC17A5—melanoma	0.000261	0.0236	CbGpPWpGaD
Triamterene—Nausea—Temozolomide—melanoma	0.000253	0.00829	CcSEcCtD
Triamterene—CYP1A2—Estrogen Receptor Pathway—GPAM—melanoma	0.000249	0.0225	CbGpPWpGaD
Triamterene—Fatigue—Docetaxel—melanoma	0.000245	0.00801	CcSEcCtD
Triamterene—SCNN1G—Transmembrane transport of small molecules—SLC6A11—melanoma	0.000237	0.0214	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—SLC6A11—melanoma	0.000237	0.0214	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—SLC6A11—melanoma	0.000237	0.0214	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—SLC6A11—melanoma	0.000237	0.0214	CbGpPWpGaD
Triamterene—Hypersensitivity—Docetaxel—melanoma	0.000209	0.00684	CcSEcCtD
Triamterene—Asthenia—Docetaxel—melanoma	0.000204	0.00666	CcSEcCtD
Triamterene—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1B1—melanoma	0.000199	0.018	CbGpPWpGaD
Triamterene—Diarrhoea—Docetaxel—melanoma	0.000194	0.00635	CcSEcCtD
Triamterene—Dizziness—Docetaxel—melanoma	0.000188	0.00614	CcSEcCtD
Triamterene—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1B1—melanoma	0.000181	0.0164	CbGpPWpGaD
Triamterene—Vomiting—Docetaxel—melanoma	0.00018	0.0059	CcSEcCtD
Triamterene—Rash—Docetaxel—melanoma	0.000179	0.00585	CcSEcCtD
Triamterene—Dermatitis—Docetaxel—melanoma	0.000179	0.00585	CcSEcCtD
Triamterene—Headache—Docetaxel—melanoma	0.000178	0.00582	CcSEcCtD
Triamterene—Nausea—Docetaxel—melanoma	0.000169	0.00552	CcSEcCtD
Triamterene—CYP1A2—Melatonin metabolism and effects—MAP2—melanoma	0.000159	0.0144	CbGpPWpGaD
Triamterene—CYP1A2—Estrogen Receptor Pathway—CYP1B1—melanoma	0.000135	0.0122	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—ARNT—melanoma	0.000128	0.0115	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—ARNT—melanoma	0.000128	0.0115	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—SLC5A5—melanoma	0.000108	0.00979	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—SLC5A5—melanoma	0.000108	0.00979	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—SLC5A5—melanoma	0.000108	0.00979	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—SLC5A5—melanoma	0.000108	0.00979	CbGpPWpGaD
Triamterene—CYP1A2—Phase II conjugation—UGT2B10—melanoma	0.000104	0.00942	CbGpPWpGaD
Triamterene—CYP1A2—Estrogen metabolism—CYP1B1—melanoma	0.000104	0.0094	CbGpPWpGaD
Triamterene—CYP1A2—Tamoxifen metabolism—CYP1B1—melanoma	9.19e-05	0.00831	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—ABCB1—melanoma	8.26e-05	0.00747	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—ABCB1—melanoma	8.26e-05	0.00747	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—ABCB1—melanoma	8.26e-05	0.00747	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—ABCB1—melanoma	8.26e-05	0.00747	CbGpPWpGaD
Triamterene—CYP1A2—Melatonin metabolism and effects—CYP1B1—melanoma	7.1e-05	0.00642	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—UGT2B10—melanoma	6.09e-05	0.00551	CbGpPWpGaD
Triamterene—CYP1A2—Melatonin metabolism and effects—EDN1—melanoma	5.74e-05	0.00519	CbGpPWpGaD
Triamterene—CYP1A2—Melatonin metabolism and effects—PRKCA—melanoma	5.38e-05	0.00487	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—ALB—melanoma	5.17e-05	0.00467	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—ALB—melanoma	5.17e-05	0.00467	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—ALB—melanoma	5.17e-05	0.00467	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—ALB—melanoma	5.17e-05	0.00467	CbGpPWpGaD
Triamterene—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—melanoma	5.15e-05	0.00466	CbGpPWpGaD
Triamterene—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—melanoma	5.14e-05	0.00465	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1B1—melanoma	4.91e-05	0.00444	CbGpPWpGaD
Triamterene—CYP1A2—Tryptophan metabolism—CYP1B1—melanoma	4.91e-05	0.00444	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—CYP1B1—melanoma	4.91e-05	0.00444	CbGpPWpGaD
Triamterene—CYP1A2—Estrogen Receptor Pathway—STAT3—melanoma	4.74e-05	0.00429	CbGpPWpGaD
Triamterene—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP17A1—melanoma	4.72e-05	0.00426	CbGpPWpGaD
Triamterene—CYP1A2—Oxidation by Cytochrome P450—CYP17A1—melanoma	4.65e-05	0.00421	CbGpPWpGaD
Triamterene—CYP1A2—Arachidonic acid metabolism—CYP1B1—melanoma	4.59e-05	0.00415	CbGpPWpGaD
Triamterene—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1B1—melanoma	3.97e-05	0.00359	CbGpPWpGaD
Triamterene—CYP1A2—Oxidation by Cytochrome P450—CYP1B1—melanoma	3.92e-05	0.00354	CbGpPWpGaD
Triamterene—CYP1A2—Metapathway biotransformation—AKR1B10—melanoma	3.87e-05	0.0035	CbGpPWpGaD
Triamterene—CYP1A2—Phase 1 - Functionalization of compounds—CYP17A1—melanoma	3.82e-05	0.00346	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—E2F1—melanoma	3.8e-05	0.00343	CbGpPWpGaD
Triamterene—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—melanoma	3.58e-05	0.00324	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—CDK2—melanoma	3.28e-05	0.00296	CbGpPWpGaD
Triamterene—CYP1A2—Phase 1 - Functionalization of compounds—CYP1B1—melanoma	3.22e-05	0.00291	CbGpPWpGaD
Triamterene—CYP1A2—Melatonin metabolism and effects—NFKB1—melanoma	2.78e-05	0.00251	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—RB1—melanoma	2.69e-05	0.00243	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—MAP2K1—melanoma	2.58e-05	0.00233	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—ACER3—melanoma	2.56e-05	0.00231	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—melanoma	2.31e-05	0.00209	CbGpPWpGaD
Triamterene—CYP1A2—Tryptophan metabolism—MDM2—melanoma	2.3e-05	0.00208	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—melanoma	2.21e-05	0.002	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—melanoma	2.1e-05	0.00189	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—melanoma	2.1e-05	0.00189	CbGpPWpGaD
Triamterene—CYP1A2—Arachidonic acid metabolism—PTGS2—melanoma	2.07e-05	0.00187	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—melanoma	2.05e-05	0.00185	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—CYP17A1—melanoma	2.03e-05	0.00184	CbGpPWpGaD
Triamterene—CYP1A2—Metapathway biotransformation—CYP17A1—melanoma	2e-05	0.00181	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—melanoma	1.93e-05	0.00175	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—melanoma	1.92e-05	0.00174	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—melanoma	1.74e-05	0.00158	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—melanoma	1.72e-05	0.00156	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—CYP1B1—melanoma	1.71e-05	0.00155	CbGpPWpGaD
Triamterene—CYP1A2—Metapathway biotransformation—CYP1B1—melanoma	1.69e-05	0.00152	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—MYC—melanoma	1.6e-05	0.00145	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—melanoma	1.57e-05	0.00142	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—melanoma	1.57e-05	0.00142	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—melanoma	1.57e-05	0.00142	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—PIP4K2A—melanoma	1.55e-05	0.0014	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—TNF—melanoma	1.49e-05	0.00135	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—melanoma	1.49e-05	0.00135	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—melanoma	1.48e-05	0.00134	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—CUBN—melanoma	1.29e-05	0.00117	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—melanoma	1.26e-05	0.00114	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—GPAM—melanoma	1.21e-05	0.00109	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—ACER3—melanoma	1.14e-05	0.00103	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—UGT2B10—melanoma	1.04e-05	0.000942	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	1.03e-05	0.00093	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—HS3ST5—melanoma	9.69e-06	0.000876	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	7.8e-06	0.000705	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PLCB4—melanoma	7.34e-06	0.000664	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—FASN—melanoma	7.21e-06	0.000652	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PIP4K2A—melanoma	6.9e-06	0.000624	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—SLC6A11—melanoma	6.9e-06	0.000624	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—MTAP—melanoma	6.72e-06	0.000607	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	6.56e-06	0.000593	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PHGDH—melanoma	5.99e-06	0.000541	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—LUM—melanoma	5.99e-06	0.000541	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—HPSE—melanoma	5.87e-06	0.000531	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—CUBN—melanoma	5.76e-06	0.000521	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—SDHD—melanoma	5.57e-06	0.000503	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—CSPG4—melanoma	5.57e-06	0.000503	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—BSG—melanoma	5.57e-06	0.000503	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—GPAM—melanoma	5.39e-06	0.000487	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PLA2G6—melanoma	4.58e-06	0.000414	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—VCAN—melanoma	4.12e-06	0.000372	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	3.9e-06	0.000352	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—melanoma	3.76e-06	0.00034	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—CYP17A1—melanoma	3.47e-06	0.000314	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	3.43e-06	0.00031	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—ALB—melanoma	3.38e-06	0.000306	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—GNA11—melanoma	3.28e-06	0.000297	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—FASN—melanoma	3.21e-06	0.00029	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—SLC5A5—melanoma	3.16e-06	0.000285	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—GNAQ—melanoma	3.05e-06	0.000276	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—CD44—melanoma	3.05e-06	0.000276	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	2.99e-06	0.00027	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—melanoma	2.96e-06	0.000267	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—CYP1B1—melanoma	2.92e-06	0.000264	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—melanoma	2.58e-06	0.000233	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—ABCB1—melanoma	2.41e-06	0.000218	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PRKCA—melanoma	2.22e-06	0.0002	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—ERCC2—melanoma	2.2e-06	0.000199	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.82e-06	0.000165	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PIK3CG—melanoma	1.74e-06	0.000157	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PPARG—melanoma	1.67e-06	0.000151	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PIK3CD—melanoma	1.53e-06	0.000138	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—ALB—melanoma	1.51e-06	0.000136	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PIK3CB—melanoma	1.33e-06	0.00012	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PTGS2—melanoma	1.32e-06	0.000119	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PTEN—melanoma	1.15e-06	0.000104	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PIK3CA—melanoma	8.11e-07	7.33e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—AKT1—melanoma	6.62e-07	5.99e-05	CbGpPWpGaD
